Director/PDMR Shareholding
1 March 2022 15:30 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 28 February 2022 awards of AstraZeneca American Depositary Shares (ADSs) vested to Dr Aradhana Sarin, Executive Director and Chief Financial Officer. Each ADS represents one half of an Ordinary Share of $0.25 in the Company. In accordance with the Agreement and Plan of Merger, the awards were granted under the AstraZeneca Global Restricted Stock Plan at the time of closing of the acquisition of Alexion Pharmaceuticals, Inc. (Alexion) by the Company.